- Presentations
- 2
- Markets
- 1
Aimovig is a brand of Erenumab marketed by Amgen, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Erenumab
- Brand owner
- Amgen
- Registered in
- United States
- Strengths and forms
- 140 mg/1 mL injection, 70 mg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Aimovig 140 mg/1 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
| Aimovig 70 mg/1 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Aimovig
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.